NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Journal
Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
medline:
13
7
2023
pubmed:
12
7
2023
entrez:
11
7
2023
Statut:
ppublish
Résumé
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
Identifiants
pubmed: 37433432
doi: 10.6004/jnccn.2023.0035
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM